Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
67.70
-0.92 (-1.34%)
At close: Jan 23, 2026, 4:00 PM EST
66.45
-1.25 (-1.85%)
After-hours: Jan 23, 2026, 5:54 PM EST
Arcellx Market Cap
Arcellx has a market cap or net worth of $3.91 billion as of January 23, 2026. Its market cap has decreased by -6.04% in one year.
Market Cap
3.91B
Enterprise Value
3.39B
1-Year Change
-6.04%
Ranking
Category
Stock Price
$67.70
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $3.91B, an increase of 678.02%. That is a compound annual growth rate of 67.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.91B | 3.83% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 4.52B |
| Amicus Therapeutics | 4.41B |
| CG Oncology | 4.34B |
| ADMA Biologics | 3.98B |
| Ligand Pharmaceuticals | 3.96B |
| NewAmsterdam Pharma Company | 3.78B |
| Terns Pharmaceuticals | 3.73B |
| Centessa Pharmaceuticals | 3.69B |